SCHEMBL5380651

SCHEMBL5380651

OCCC=Cc1nn(Cc2ccc(Cl)cc2F)c2cc(OC(F)(F)F)ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 3/20 0.39
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
RORC P51449 1/20 0.36
F2RL3 Q96RI0 6/20 0.35
GRM2 Q14416 1/20 0.34
PPARG P37231 3/20 0.33
PPARA Q07869 2/20 0.33
CYP2C9 P11712 2/20 0.33
EGFR P00533 1/20 0.33
CHRM4 P08173 1/20 0.33
ADRB1 P08588 1/20 0.33
ADRA2A P08913 1/20 0.33
ALOX5 P09917 1/20 0.33
ADRB3 P13945 1/20 0.33
DRD2 P14416 1/20 0.33
ADRA2B P18089 1/20 0.33
CHRM3 P20309 1/20 0.33
TACR2 P21452 1/20 0.33
DRD1 P21728 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5380645 1.00 ENPP2 (0.39) ENPP2NR1H2NR1H3RORCF2RL3
SCHEMBL5337868 0.95 ENPP2 (0.38) ENPP2NR1H2NR1H3RORCF2RL3
SCHEMBL5337864 0.95 ENPP2 (0.38) ENPP2NR1H2NR1H3RORCF2RL3
SCHEMBL5317033 0.93 ENPP2 (0.40) ENPP2NR1H2NR1H3RORCF2RL3
SCHEMBL5317032 0.93 ENPP2 (0.40) ENPP2NR1H2NR1H3RORCF2RL3
SCHEMBL5348942 0.92 CYP1A2 (0.39) ENPP2F2RL3PPARGCYP2C9CYP2D6
SCHEMBL5348946 0.92 CYP1A2 (0.39) ENPP2F2RL3PPARGCYP2C9CYP2D6
SCHEMBL5336983 0.91 F2RL3 (0.43) ENPP2RORCF2RL3CYP2C9PTGDR
SCHEMBL5336985 0.91 F2RL3 (0.43) ENPP2RORCF2RL3CYP2C9PTGDR
SCHEMBL5342922 0.90 ENPP2 (0.37) ENPP2F2RL3PPARGPPARACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed